We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

QPharma Appoints Chief Medical Officer

News   May 17, 2013

 
QPharma Appoints Chief Medical Officer
 
 
 

RELATED ARTICLES

Study Identifies Effective Ketamine Doses for Treatment-Resistant Depression

News

Study identifies two subanesthetic dosage levels of the anesthetic drug ketamine that appear to provide significant symptom relief to patients with treatment-resistant depression.

READ MORE

Paralysis from Rare Disorder: Stem Cell Therapy Trial Brings Hope

News

A clinical trial is planned to see if a single injection of progenitor cells can help repair spinal cords inflamed by transverse myelitis.

READ MORE

On-demand, Adaptable and Automated Biopharmaceutical Manufacturing

News

Having the ability to produce small batches of drugs makes precision medicine a reality, and accelerates drug development.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE